Fosmax (Alendronate Sodium PR
| PATRICK WELCH |
| MERCK SHARP & DOHME, BARR PHARM INC, RP, a Delaware Corporation, BARR LABORATORIES, a Delawarre Corporation, TEVA PHARM USA INC, a Delware Corporation, WATSON LAB, a Nevada Corporation, WATSON PHARMACEUTICALS INC, a Nevada corporation, MYLAN INC, a Pennsylvania Corporation, FKA Mylan Lab Inc, MYLAN PHARM INC, a west Virginia corporation, APOTEX CORP, A Delaware Corporation, SUN PHARMA GLOBAL, a Michigan Corporation, FKA Caraco Pharmaceutical Laboratories Ltd, SUN PHARMACEUTICAL INDUSTRIES INC, a Michigan corporation, WATSON PHARMACEUTICALS INC, FKA Cobalt Pharmaceuticals Company, AKA Watson Pharmaceuticals Inc and COBALT LABORATORIES INC |
| 12-2250 |
| June 21, 2012 |
| U.S. Court of Appeals, Third Circuit |
| Personal Injury-Product Liability |
Opinions
We have the following opinions for this case:
| Description |
|---|
 In re: Fosmax (Alendronate Sodium)
|
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
3011602998
PRECEDENTIAL OPINION Coram: JORDAN, VANASKIE and GREENBERG, Circuit Judges. Total Pages: 34. Judge: JORDAN, Authoring. We will affirm the District Court's judgment for the Generic Defendants. (NDA- resent, spelling of Stadtmauer's name corrected.)
|
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
